• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Biosimilars Market

    ID: MRFR/LS/12318-HCR
    100 Pages
    MRFR Team
    September 2025

    United States Biosimilars Market Research Report to 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Biosimilars Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Infographic

    US Biosimilars Market Summary

    The US Biosimilars market is projected to grow from 35 USD Billion in 2024 to 90 USD Billion by 2035.

    Key Market Trends & Highlights

    US Biosimilars Key Trends and Highlights

    • The US Biosimilars market is valued at 35 USD Billion in 2024.
    • By 2035, the market is expected to reach 90 USD Billion, indicating substantial growth.
    • The compound annual growth rate (CAGR) for the period from 2025 to 2035 is estimated at 8.97%.
    • Growing adoption of biosimilars due to increasing healthcare costs is a major market driver.

    Market Size & Forecast

    2024 Market Size 35 (USD Billion)
    2035 Market Size 90 (USD Billion)
    CAGR (2025 - 2035) 8.97%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    Key Companies in the US Biosimilars Market market include

    FAQs

    What is the expected market size of the US Biosimilars Market in 2024?

    The US Biosimilars Market is projected to be valued at 3.5 billion USD in 2024.

    What will be the market size of the US Biosimilars Market by 2035?

    By 2035, the market size is expected to reach 9.0 billion USD.

    What is the expected compound annual growth rate (CAGR) for the US Biosimilars Market from 2025 to 2035?

    The expected CAGR for the US Biosimilars Market during this period is 8.965%.

    Which product type dominates the US Biosimilars Market?

    Monoclonal antibodies are anticipated to be a leading segment, valued at 1.4 billion USD in 2024.

    How is the recombinant proteins segment projected to grow by 2035?

    The recombinant proteins segment is expected to increase to 2.7 billion USD by 2035.

    What market value is expected for insulin biosimilars in 2024?

    The market value for insulin biosimilars is projected to be 0.7 billion USD in 2024.

    What is the anticipated market size for hormone biosimilars by 2035?

    Hormone biosimilars are expected to reach a market size of 0.9 billion USD by 2035.

    Who are the key players currently operating in the US Biosimilars Market?

    Major players include Teva Pharmaceutical Industries, Genentech, and Bristol Myers Squibb among others.

    What growth opportunities exist in the US Biosimilars Market?

    The growing demand for cost-effective biologics presents significant growth opportunities in the market.

    How are external market dynamics impacting the US Biosimilars Market?

    Current global scenarios and conflicts are likely to create both challenges and opportunities in the market landscape.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027